These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 11281757)

  • 1. Synthesis, chemical properties, and biological evaluation of CC-1065 and duocarmycin analogues incorporating the 5-methoxycarbonyl-1,2,9,9a-tetrahydrocyclopropa.
    Boger DL; Hughes TV; Hedrick MP
    J Org Chem; 2001 Apr; 66(7):2207-16. PubMed ID: 11281757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of a series of C3-substituted CBI analogues of CC-1065 and the duocarmycins.
    Boger DL; Brunette SR; Garbaccio RM
    J Org Chem; 2001 Jul; 66(15):5163-73. PubMed ID: 11463270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 1,2,8, 8a-Tetrahydrocyclopropa[c]pyrrolo[3,2-e]indol-4(5H)-one, the parent alkylation subunit of CC-1065 and the duocarmycins: impact of the alkylation subunit substituents and its implications for DNA alkylation catalysis.
    Boger DL; Santillán A; Searcey M; Brunette SR; Wolkenberg SE; Hedrick MP; Jin Q
    J Org Chem; 2000 Jun; 65(13):4101-11. PubMed ID: 10866627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel synthesis and evaluation of 132 (+)-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogues of CC-1065 and the duocarmycins defining the contribution of the DNA-binding domain.
    Boger DL; Schmitt HW; Fink BE; Hedrick MP
    J Org Chem; 2001 Oct; 66(20):6654-61. PubMed ID: 11578217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substituent effects within the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Boger DL; Stauffer F; Hedrick MP
    Bioorg Med Chem Lett; 2001 Aug; 11(15):2021-4. PubMed ID: 11454471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Properties of Substituted CBI Analogs of CC-1065 and the Duocarmycins Incorporating the 7-Methoxy-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-one (MCBI) Alkylation Subunit: Magnitude of Electronic Effects on the Functional Reactivity.
    Boger DL; McKie JA; Cai H; Cacciari B; Baraldi PG
    J Org Chem; 1996 Mar; 61(5):1710-1729. PubMed ID: 11667041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,2,9,9a-Tetrahydrocyclopropa[c]benz[e]indol-4-one (CBI) analogs of CC-1065 and the duocarmycins: synthesis and evaluation.
    Boger DL; Yun W; Han N
    Bioorg Med Chem; 1995 Nov; 3(11):1429-53. PubMed ID: 8634824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of functional analogs of CC-1065 and the duocarmycins incorporating the cross-linking 9a-chloromethyl-1,2,9,9a-tetrahydrocyclopropa[c]benz[e]indol-4-on e (C2BI) alkylation subunit.
    Boger DL; Johnson DS; Palanki MS; Kitos PA; Chang J; Dowell P
    Bioorg Med Chem; 1993 Jul; 1(1):27-38. PubMed ID: 8081835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of duocarmycin and CC-1065 analogues incorporating the 1,2,9,9a-tetrahydrocyclopropa[c]benz[e]-3-azaindol-4-one (CBA) alkylation subunit.
    Parrish JP; Kastrinsky DB; Hwang I; Boger DL
    J Org Chem; 2003 Nov; 68(23):8984-90. PubMed ID: 14604371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective metal cation activation of a DNA alkylating agent: synthesis and evaluation of methyl 1,2,9, 9a-Tetrahydrocyclopropa[c]pyrido[3,2-e]indol-4-one-7-carboxylate (CPyI).
    Boger DL; Boyce CW
    J Org Chem; 2000 Jun; 65(13):4088-100. PubMed ID: 10866626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CBI-CDPBO1 and CBI-CDPBI1: CC-1065 analogs containing deep-seated modifications in the DNA binding subunit.
    Boger DL; Yun W; Cai H; Han N
    Bioorg Med Chem; 1995 Jun; 3(6):761-7. PubMed ID: 7582954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metal cation complexation and activation of reversed CPyI analogues of CC-1065 and duocarmycin SA: partitioning the effects of binding and catalysis.
    Ellis DA; Wolkenberg SE; Boger DL
    J Am Chem Soc; 2001 Sep; 123(38):9299-306. PubMed ID: 11562212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of substituent effects in the DNA binding subunit of CBI analogues of the duocarmycins and CC-1065.
    Parrish JP; Kastrinsky DB; Stauffer F; Hedrick MP; Hwang I; Boger DL
    Bioorg Med Chem; 2003 Aug; 11(17):3815-38. PubMed ID: 12901927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CC-1065/duocarmycin and bleomycin A2 hybrid agents: lack of enhancement of DNA alkylation by attachment to noncomplementary DNA binding subunits.
    Boger DL; Han N
    Bioorg Med Chem; 1997 Feb; 5(2):233-43. PubMed ID: 9061188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duocarmycins--natures prodrugs?
    Searcey M
    Curr Pharm Des; 2002; 8(15):1375-89. PubMed ID: 12052214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing the parabolic relationship between reactivity and activity for derivatives and analogues of the duocarmycin and CC-1065 alkylation subunits.
    Parrish JP; Hughes TV; Hwang I; Boger DL
    J Am Chem Soc; 2004 Jan; 126(1):80-1. PubMed ID: 14709069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI) subunit of the antitumor agent CC-1065 and polypyrrole minor groove binders.
    Baraldi PG; Balboni G; Pavani MG; Spalluto G; Tabrizi MA; Clercq ED; Balzarini J; Bando T; Sugiyama H; Romagnoli R
    J Med Chem; 2001 Aug; 44(16):2536-43. PubMed ID: 11472207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bifunctional alkylating agents derived from duocarmycin SA: potent antitumor activity with altered sequence selectivity.
    Boger DL; Searcey M; Tse WC; Jin Q
    Bioorg Med Chem Lett; 2000 Mar; 10(5):495-8. PubMed ID: 10743956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activation.
    Boger DL; Garbaccio RM
    Bioorg Med Chem; 1997 Feb; 5(2):263-76. PubMed ID: 9061191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for sequence selective DNA alkylation by (+)- and ent-(-)-CC-1065 and related agents: alkylation site models that accommodate the offset AT-rich adenine N3 alkylation selectivity.
    Boger DL; Johnson DS; Yun W; Tarby CM
    Bioorg Med Chem; 1994 Feb; 2(2):115-35. PubMed ID: 7922122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.